Global Market Study on Obesity Surgery Devices: Asia-Pacific to Witness Highest Growth by 2020


  • Published On : Jul-2014 |
  • Pages : 73 Pages |
  • Format :

Obesity is a chronic metabolic and genetic disease involving accumulation of excessive or abnormal fat in the body. Obesity surgeries decrease the size of the stomach, in order to limit the amount of food it can hold. This limits the quantity of food patients can ingest, leading to drastic weight loss. It has a beneficial effect on many medical conditions such as acid reflux, low back pain, diabetes, sleep apnea, hypertension, acid reflux, polycystic ovary syndrome (PCOS) and urinary stress incontinence. Increasing prevalence of obesity among children and adults is posing a threat in both developed and developing nations. Obesity has a major impact on population longevity and health-related expenses. Obesity surgeries result in 40% to 80% loss of excess weight after two to three years, depending on the obesity surgery procedure.

North America is facing serious public health issues due to rising obesity in the country. The U.S. accounted for 13% of obese persons worldwide in 2013. Obesity is a major public health challenge in Europe. Approximately, 52% of the population in the European Union was obese or overweight in 2010. Obesity has reached epidemic proportions in many countries in Asia Pacific. South East Asia and Western Pacific regions are facing an epidemic of obesity-associated diseases such as cardiovascular disorders and diabetes. Some of the leading factors leading to obesity in the region are sedentary lifestyle, lack of awareness and cultural attitude.

Increasing obesity epidemic and change in lifestyle are driving growth for obesity surgery devices market. Changes in nature of work, leisure time activities and food habits are the most significant contributing factors to the drastic increase of obesity in the world. In addition, increased medical tourism promotes obesity surgeries, as price is considered to be an important factor when it comes to obesity surgery. However, the selective nature of the surgery, long-term and short-term complications undergoing surgeries and limited insurance coverage restricts growth for the obesity surgery devices market. Obesity surgery is also not recommended for anyone suffering from serious illnesses such as cancer, liver diseases, cardiac, pulmonary and renal insufficiency. In addition, inadequate insurance coverage for the procedure and excessive cost of surgery often makes it unaffordable.

This report provides in-depth analysis and estimation of the obesity surgery devices market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The obesity surgery devices market is categorized on the basis of procedure for obesity surgery, devices and geography. Based on procedure of obesity surgery, the obesity surgery devices market comprises adjustable gastric banding, sleeve gastrectomy, Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch. Based on devices, the market comprises staples, intragastric balloons, gastric bands and gastric electrical stimulation.
 

In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row).

Globally, the obesity surgery devices market is witnessing significant growth due to increasing obesity epidemic and increasing sedentary lifestyle and junk food habits. Increasing prevalence of obesity among children and adults is posing a threat in both developed and developing nations. Excess body weight directly contributes to increasing risk of stroke, heart diseases, type-2 diabetes and some forms of cancer. Obesity surgery is a broadly available treatment for persons with severe and complex obesity. However, inadequate insurance coverage for the procedure and excessive cost of surgery often makes it unaffordable. In addition, selective nature of obesity surgery, due to its complications, restricts growth of obesity surgery devices market.

The global obesity surgery device market is estimated at USD 1,432.4 million in 2014. It is likely to grow at a CAGR of 9.6% from 2014 to 2020 to reach USD 2,489.5 million in 

2020.

North America is the largest market for global obesity surgery devices. Roux-en-Y gastric bypass is the largest procedure of obesity surgery and staples is the largest type of obesity surgery device. In terms of growth, Asia Pacific is the fastest growing region, sleeve gastrectomy is the fastest growing procedure and gastric electrical stimulation is the fastest growing type of obesity surgery device.

North America obesity surgery devices market was valued at USD 968.7 million in 2014 and is expected to reach USD 1,665.2 million in 2020, growing at a CAGR of 9.4% from 2014 to 2020.

Roux-en-Y gastric bypass procedure for obesity surgery was valued at USD 691.4 million in 2014 and is expected to reach USD 1,225.9 million in 2020, growing at a CAGR of 10% from 2014 to 2020.

Some of the major players in the obesity surgery devices market:

  • Johnson & Johnson.
  • Medtronic, Inc.
  • Apollo Endosurgery Inc.
  • Aspire Bariatrics.
  • Spatz FGIA Inc.
  • MetaCure.
  • IntraPace Inc.
  • Other.

These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.

Table of Content

Chapter 1 Preface 9

1.1 Report Description 9

1.2 Research Methodology 10

1.3 Assumptions 10

Chapter 2 Market Synopsis 11

Chapter 3 Porter Five Forces Analysis 13

3.1 Bargaining power of suppliers 13

3.2 Bargaining power of buyers 14

3.3 Threat of new entrants 14

3.4 Threat of substitutes 14

3.5 Intensity of rivalry 14

Chapter 4 Industry Overview 15

4.1 Market Definition 15

4.2 Market Drivers 17

      4.2.1 Global obesity endemic 17

      4.2.2 Increasing sedentary lifestyle and junk food habits lead to obesity 18

      4.2.3 Increasing prevalence of childhood obesity 19

      4.2.4 Increasing medical tourism promotes medical surgery 20

4.3 Impact Analysis of Market Drivers 21

4.4 Market Restraints 22

      4.4.1 Selective nature of obesity surgery 22

      4.4.2 Long-term and short-term complication restrict patient from undergoing surgery 22

      4.4.3 Limited insurance coverage for obesity surgery 23

4.5 Impact Analysis of Market Restraints 23

4.6 Market Trends 24

      4.6.1 Demand for less invasive procedures for obesity surgery 24

      4.6.2 Increasing demand for gastric electrical stimulation 24

Chapter 5 Global Market Size and Forecast 25

Chapter 6 Market Size and Forecast by Procedure 31

6.1 Sleeve Gastrectomy 31

6.2 Adjustable Gastric Banding 33

6.3 Roux-en-Y Gastric Bypass 35

6.4 Biliopancreatic Diversion with Duodenal Switch 37

Chapter 7 Market Size and Forecast by Devices 40

7.1 Intragastric Balloons 40

7.2 Gastric electrical stimulators 42

7.3 Gastric bands 44

7.4 Staples 46

Chapter 8 Market Size and Forecast by Geography 49

8.1 North America 49

8.2 Europe 51

8.3 Asia Pacific 54

8.4 Rest of the World 56

Chapter 9 Competitive Scenario 57

9.1 Competitive Benchmarking 57

Chapter 10 Company Profiles 59

10.1 Johnson & Johnson 59

      10.1.1 Company Overview 59

      10.1.2 Products and Services 59

      10.1.3 Financial Performance 59

      10.1.4 Recent Developments 60

10.2 Medtronic Inc 61

      10.2.1 Company Overview 61

      10.2.2 Products and Services 61

      10.2.3 Financial Performance 61

      10.2.4 Recent Developments 62

10.3 Aspire Bariatrics 63

      10.3.1 Company Overview 63

      10.3.2 Products and Services 63

      10.3.3 Financial Performance 63

      10.3.4 Recent Developments 63

10.4 Apollo Endosurgery, Inc 64

      10.4.1 Company Overview 64

      10.4.2 Products and Services 64

      10.4.3 Financial Performance 64

      10.4.4 Recent Developments 65

10.5 USGI Medical, Inc. 66

      10.5.1 Company Overview 66

      10.5.2 Products and Services 66

      10.5.3 Financial Performance 66

      10.5.4 Recent Developments 67

10.6 Spatz FGIA, Inc. 68

      10.6.1 Company Overview 68

      10.6.2 Products and Services 68

      10.6.3 Financial Performance 68

      10.6.4 Recent Developments 68

10.7 W.L. Gore & Associates, Inc 69

      10.7.1 Company Overview 69

      10.7.2 Products and Services 69

      10.7.3 Financial Performance 69

      10.7.4 Recent Developments 69

10.8 IntraPace, Inc. 70

      10.8.1 Company Overview 70

      10.8.2 Products and Services 70

      10.8.3 Financial Performance 70

      10.8.4 Recent Developments 70

10.9 MetaCure 71

      10.9.1 Company Overview 71

      10.9.2 Products and Services 71

      10.9.3 Financial Performance 71      

      10.9.4 Recent Developments 71

10.10 ReShape Medical, Inc. 72

      10.10.1 Company Overview 72

      10.10.2 Products and Services 72

      10.10.3 Financial Performance 72

      10.10.4 Recent Developments 72


List of Tables

TABLE 1 Market Snapshot: Obesity Surgery Devices Market (2014 & 2020) 11

TABLE 2 Prevalence of obesity (%) by region, gender and age 20

TABLE 3 Cost of gastric bypass surgery in various countries and average saving compared to the U.S. 21

TABLE 4 Drivers for obesity surgery devices market: Impact analysis 21

TABLE 5 Restraints of obesity surgery devices market: impact analysis 23

TABLE 6 Global obesity surgery device market size by region, 2010-2013 (USD Million) 26

TABLE 7 Global obesity surgery devices market size by region, 2014-2020 (USD Million) 26

TABLE 8 Global obesity surgery devices market by procedure 2010 - 2013 (USD Million) 27

TABLE 9 Global obesity surgery devices market volume and forecast, by geography 2014 - 2020 (thousand tons) 28

TABLE 10 Global obesity surgery devices market by devices 2010 - 2013 (USD Million) 29

TABLE 11 Global obesity surgery devices market by devices 2014 - 2020 (USD Million) 30

TABLE 12 Global sleeve gastrectomy procedure market size by region 2010 - 2013 (USD Million) 32

TABLE 13 Global sleeve gastrectomy procedure market size by region 2014 - 2020 (USD Million) 32

TABLE 14 Global adjustable gastric banding procedure market by region 2010 - 2013 (USD Million) 34

TABLE 15 Global adjustable gastric banding market by region 2014 - 2020 (USD Million) 34

TABLE 16 Global Roux-en-Y gastric bypass procedure market by region 2010 - 2013 (USD Million) 36

TABLE 17 Global Roux-en-Y gastric bypass procedure market by geography 2014 - 2020 (USD Million) 36

TABLE 18 Global biliopancreatic diversion with duodenal switch procedure market by region 2010 - 2013 (USD Million) 38

TABLE 19 Global biliopancreatic diversion with duodenal switch procedure market by region 2014 - 2020 (USD Million) 38

TABLE 20 Global intragastric balloon device market by geography 2010 - 2013 (USD Million) 41

TABLE 21 Global intragastric balloon device market by geography 2014 - 2020 (USD Million) 41

TABLE 22 Global gastric electrical stimulator device market by geography 2010 - 2013 (USD Million) 43

TABLE 23 Global gastric electrical stimulator market by geography 2014 - 2020 (USD Million) 43

TABLE 24 Global gastric band devices market by geography 2010 - 2013 (USD Million) 45

TABLE 25 Global gastric band device market by geography 2014 - 2020 (USD Million) 45

TABLE 26 Global staples device market by geography 2010 - 2013 (USD Million) 47

TABLE 27 Global staples device market by geography 2014 - 2020 (USD Million) 47

TABLE 28 The North American obesity surgery devices market size by country, 2010 - 2013 (USD Million) 50

TABLE 29 The North American obesity surgery market size by country, 2014 - 2020 (USD Million) 51

TABLE 30 The European obesity surgery devices market size by country, 2010 - 2013 (USD Million) 52

TABLE 31 The European obesity surgery devices market size by country, 2014 - 2020 (USD Million) 53

TABLE 32 Asia Pacific obesity surgery devices market size by country, 2010 - 2013 (USD Million) 55

TABLE 33 Asia Pacific obesity surgery devices market size by country 2014 - 2020 (USD Million) 56

TABLE 34 Some of the other players in obesity surgery devices market 58

TABLE 35 Major categories and products of Johnson & Johnson 59

TABLE 36 Some of the major products and services of Medtronic 61

TABLE 37 Product of Aspire Bariatrics and its application 63

TABLE 38 Some of the major products of Apollo Endosurgery and their applications 64

TABLE 39 Some of the major USGI Medical products and their applications 66

TABLE 40 Spatz FGIA product and its application 68

TABLE 41 Some of the major W. L. Gore & Associate’s products and their applications 69

TABLE 42 IntraPace product and its application 70

TABLE 43 MetaCure’s product and its application 71

TABLE 44 ReShape Medical’s product and its application 72


List of Figures 

FIG. 1 Obesity surgery devices market: Porters Five Force Analysis 13

FIG. 2 Some benefits of obesity surgery 15

FIG. 3 Types of obesity surgery procedures 16

FIG. 4 Prevalence of overweight or obese males and females aged 30 years and above (2005 and 2015 %) 17

FIG. 5 Frequency of consumption of fast food in the U.S. 19

FIG. 6 Global obesity surgery devices market share by region, by value, 2013 and 2020 25

FIG. 7 Global obesity surgery devices market share by procedure, by value, 2013 and 2020 27

FIG. 8 Global obesity surgery devices market share by devices, by value, 2013 and 2020 29

FIG. 9 Global sleeve gastrectomy procedure market share by region, by value, 2013 and 2020 31

FIG. 10 Global adjustable gastric banding procedure market share by region, by value, 2013 and 2020 33

FIG. 11 Global Roux-en-Y gastric bypass procedure market share by region, by value, 2013 and 2020 35

FIG. 12 Global biliopancreatic Diversion with duodenal switch procedure market share by region, by value, 2013 and 2020 37

FIG. 13 Global intragastric balloon device market share by region, by value, 2013 and 2020 40

FIG. 14 Global gastric electrical stimulator devices market share by region, by value, 2013 and 2020 42

FIG. 15 Global gastric band devices market share by region, by value, 2013 and 2020 44

FIG. 16 Global staples devices market share by region, by value, 2013 and 2020 46

FIG. 17 The North American obesity surgery devices market share by country, by value, 2013 and 2020 50

FIG. 18 The European obesity surgery devices market share by country, by value, 2013 and 2020 52

FIG. 19 Asia Pacific obesity surgery devices market share by region, by value, 2013 and 2020 55

FIG. 20 Competitive benchmarking of obesity surgery devices market 57

FIG. 21 Johnson & Johnson sales and net earnings 2011-2013 (USD Million) 60

FIG. 22 Medtronic net sales and net earnings 2011-2013 (USD Million) 62

Back To Top